Provenance du réseau au premier degré de Christina Brattström
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 7 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Christina Brattström via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| Karolinska Institutet | College/University | Doctorate Degree Corporate Officer/Principal | |
| MENDUS AB | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| ELICERA THERAPEUTICS AB | Biotechnology | Director/Board Member Director/Board Member | |
| MIDSONA AB | Pharmaceuticals: Other | Director of Finance/CFO | |
| University of Warwick | College/University | Doctorate Degree | |
| ONCOPEPTIDES AB | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Kalmar | College/University | Graduate Degree | |
| Rotterdam University of Applied Sciences | College/University | Undergraduate Degree | |
| University of South Australia | College/University | Undergraduate Degree | |
| University of Surrey | College/University | Undergraduate Degree | |
| Centre For Advanced Medical Products | Director/Board Member | ||
Gadeta BV
 Gadeta BV Medical SpecialtiesHealth Technology Gadeta BV discovers and develops novel cancer immunotherapies. It provides groundbreaking discoveries regarding the role of cell receptors in the broad of heamatological and solid tumor cells. The firm develops t-cells engineered to express a defined gamma delta, an anti- cancer product that eradicates tumors. The company was founded by Jurgen Kuball in 2015 and is headquartered in Utrecht, Netherlands. | Medical Specialties | Corporate Officer/Principal | |
| University of Stockholm | College/University | Masters Business Admin | |
Janssen Biologics BV
 Janssen Biologics BV Pharmaceuticals: MajorHealth Technology Janssen Biologics BV manufactures, acquires and markets biopharmaceutical therapies. The firms products focus on cardiovascular and immunological disorders, and cancer. The company was founded in 1984 and is headquartered in Leiden, the Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Utrecht | College/University | Doctorate Degree | |
| University of Leiden | College/University | Graduate Degree | |
| University of Lund | College/University | Doctorate Degree | |
| WNTRESEARCH AB | Pharmaceuticals: Other | Corporate Officer/Principal | |
| Capio St Gorans Hospital | Corporate Officer/Principal |
Statistiques
Internationale
| Suède | 12 |
| Pays-Bas | 6 |
| Royaume-Uni | 3 |
| Australie | 2 |
| Suisse | 2 |
Sectorielle
| Consumer Services | 11 |
| Health Technology | 9 |
Opérationnelle
| Corporate Officer/Principal | 9 |
| Director/Board Member | 6 |
| Doctorate Degree | 5 |
| Independent Dir/Board Member | 3 |
| Undergraduate Degree | 3 |
Relations les plus connectées
- Bourse
- Insiders
- Christina Brattström
- Connexions Sociétés
